{"id":396743,"date":"2025-04-19T01:05:00","date_gmt":"2025-04-18T23:05:00","guid":{"rendered":"https:\/\/medizinonline.com\/non-ci-saranno-piu-trapianti-per-la-hl-recidivata-o-refrattaria-in-futuro\/"},"modified":"2025-04-19T00:00:51","modified_gmt":"2025-04-18T22:00:51","slug":"non-ci-saranno-piu-trapianti-per-la-hl-recidivata-o-refrattaria-in-futuro","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/it\/non-ci-saranno-piu-trapianti-per-la-hl-recidivata-o-refrattaria-in-futuro\/","title":{"rendered":"Non ci saranno pi\u00f9 trapianti per la HL recidivata o refrattaria in futuro?"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>L&#8217;approccio terapeutico standard per il linfoma di Hodgkin classico (HL) recidivato o refrattario (RR), dopo il fallimento del trattamento di prima linea, \u00e8 la terapia di seconda linea con l&#8217;obiettivo di raggiungere la remissione completa (CR), seguita dal consolidamento con la terapia ad alte dosi e il trapianto di cellule ematopoietiche autologhe (HDT\/AHCT). I ricercatori hanno studiato se in futuro si potr\u00e0 rinunciare al trapianto in determinate condizioni. <\/strong><\/p>\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fnon-ci-saranno-piu-trapianti-per-la-hl-recidivata-o-refrattaria-in-futuro%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>L&#8217;approccio terapeutico standard per il linfoma di Hodgkin classico (HL) recidivato o refrattario (RR), dopo il fallimento del trattamento di prima linea, \u00e8 la terapia di seconda linea con l&#8217;obiettivo&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/it\/il-mio-conto\/pacchetti\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">Already a member? <a href=\"https:\/\/medizinonline.com\/it\/effettuare-il-login\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fit%2Fnon-ci-saranno-piu-trapianti-per-la-hl-recidivata-o-refrattaria-in-futuro%2F\">Accedi<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Linfoma di Hodgkin  ","footnotes":""},"category":[11550,11361,11376,11522,11515],"tags":[81784,25782,13024,81822,15807,30343],"powerkit_post_featured":[],"class_list":["post-396743","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-it","category-ematologia","category-oncologia-it","category-rapporti-del-congresso","category-studi","tag-ash-2024-it","tag-hl-it","tag-linfoma-di-hodgkin","tag-linfoma-di-hodgkin-it-2","tag-pembrolizumab-it","tag-trapianto","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-07-13 12:02:53","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"it_IT","wpml_translations":{"pt_PT":{"locale":"pt_PT","id":396739,"slug":"nao-havera-mais-transplantes-para-o-lh-recidivante-ou-refratario-no-futuro","post_title":"N\u00e3o haver\u00e1 mais transplantes para o LH recidivante ou refrat\u00e1rio no futuro?","href":"https:\/\/medizinonline.com\/pt-pt\/nao-havera-mais-transplantes-para-o-lh-recidivante-ou-refratario-no-futuro\/"},"es_ES":{"locale":"es_ES","id":396733,"slug":"no-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro","post_title":"\u00bfNo habr\u00e1 m\u00e1s trasplantes para el LH recidivante o refractario en el futuro?","href":"https:\/\/medizinonline.com\/es\/no-habra-mas-trasplantes-para-el-lh-recidivante-o-refractario-en-el-futuro\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/396743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/comments?post=396743"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/396743\/revisions"}],"predecessor-version":[{"id":398459,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/posts\/396743\/revisions\/398459"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media\/396747"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/media?parent=396743"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/category?post=396743"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/tags?post=396743"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/it\/wp-json\/wp\/v2\/powerkit_post_featured?post=396743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}